Status:
WITHDRAWN
LLLT Treatment of Lung Inflammation in COVID-19
Lead Sponsor:
Ward Photonics LLC
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To determine if a reduction of pneumonic inflammation occurs after treatment with Low-Level Laser Therapy (LLLT) applying red-light technology in the respiratory system of COVID-19 patients suffering ...
Detailed Description
This clinical trial is a blinded before and after comparison of the effect on patients treated with a red-light LLLT therapy for acute lung inflammation as a result of COVID-19 infection. Patients are...
Eligibility Criteria
Inclusion
- Participant is diagnosed with COVID-19.
- Study participant is 18 years of age or older.
- Patient exhibiting moderate-to-acute respiratory distress.
Exclusion
- Photosensitive condition or medication.
- Active chemotherapy treatment or other cancer treatment.
- Autoimmune Disorder.
- Pregnant, possibly pregnant or planning pregnancy prior to the end of study participation.
- Developmental disability or cognitive impairment that, in the opinion of the investigator, would preclude adequate comprehension of the informed consent form and/or ability to record the necessary study measurements.
Key Trial Info
Start Date :
July 31 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04524715
Start Date
July 31 2021
End Date
March 31 2022
Last Update
July 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wellness Junction
Millsboro, Delaware, United States, 19966